Treatment of primary liver cancer: SARAH study now available for all eligible ... Canada NewsWire (press release) ... microspheres are approved for use in Australia, the European Union (CE Mark), New Zealand, Switzerland, Turkey and several other countries including in Asia (e.g. India, Korean, Singapore and Hong Kong) for the treatment of unresectable liver tumours. |
